We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+32.49%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+608.47%
AUM
$303B
AUM Growth
+$68.2B
Cap. Flow
+$27.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
20.13%
Holding
6,442
New
553
Increased
3,286
Reduced
1,432
Closed
758

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.36B
2
TSLA icon
Tesla
TSLA
+$1.09B
3
AMZN icon
Amazon
AMZN
+$1B
4
MSFT icon
Microsoft
MSFT
+$963M
5
AAPL icon
Apple
AAPL
+$864M

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.44%
2 Technology 25.75%
3 Financials 6.27%
4 Consumer Discretionary 5.79%
5 Industrials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZM icon
4726
Lifezone Metals
LZM
$326M
$70.9K ﹤0.01%
18,266
+16,669
+1,044% +$77.9K
LYEL icon
4727
Lyell Immunopharma
LYEL
$261M
$70.6K ﹤0.01%
5,025
-887
-15% -$16.1K
MDWD icon
4728
MediWound
MDWD
$171M
$70.5K ﹤0.01%
4,795
+4,281
+833% +$68K
IMUX icon
4729
Immunic
IMUX
$139M
$70.2K ﹤0.01%
+4,569
New +$56.4K
SND icon
4730
Smart Sand
SND
$220M
$70K ﹤0.01%
13,976
+6,558
+88% +$33K
SCHM icon
4731
Schwab US Mid-Cap ETF
SCHM
$14.4B
$70K ﹤0.01%
1,899
+137
+8% +$4.71K
ECBK icon
4732
ECB Bancorp
ECBK
$183M
$69.7K ﹤0.01%
3,469
+2,963
+586% +$54.7K
PRLD icon
4733
Prelude Therapeutics
PRLD
$354M
$69.5K ﹤0.01%
13,033
+13,028
+260,560% +$56.7K
ELTX icon
4734
Elicio Therapeutics
ELTX
$46.5M
$69.3K ﹤0.01%
+17,726
New +$178K
DOMO icon
4735
Domo
DOMO
$180M
$69.3K ﹤0.01%
22,125
+20,215
+1,058% +$67.6K
GRVY
4736
GRAVITY
GRVY
$486M
$69.2K ﹤0.01%
1,031
+308
+43% +$19.2K
IGA
4737
Voya Global Advantage and Premium Opportunity Fund
IGA
$163M
$69K ﹤0.01%
6,973
+1,564
+29% +$15.2K
AXIA.PRC
4738
DELISTED
AXIA Energia American Depositary Shares Preferred Class C
AXIA.PRC
$69K ﹤0.01%
6,539
-223
-3% -$2.44K
WHWK
4739
Whitehawk Therapeutics
WHWK
$231M
$68.8K ﹤0.01%
15,019
+8,860
+144% +$36.9K
MOMO
4740
Hello Group
MOMO
$704M
$68.6K ﹤0.01%
11,834
-15,223
-56% -$90.9K
SPRB
4741
Spruce Biosciences
SPRB
$156M
$68.3K ﹤0.01%
1,265
+326
+35% +$18.2K
TNYA icon
4742
Tenaya Therapeutics
TNYA
$148M
$68.3K ﹤0.01%
92,417
+46,375
+101% +$35.2K
KRRO icon
4743
Korro Bio
KRRO
$208M
$68.1K ﹤0.01%
5,169
+4,861
+1,578% +$60.4K
RAIL icon
4744
FreightCar America
RAIL
$235M
$67.9K ﹤0.01%
6,976
-6,472
-48% -$54.5K
VTWO icon
4745
Vanguard Russell 2000 ETF
VTWO
$16.7B
$67.6K ﹤0.01%
557
EVCM icon
4746
EverCommerce
EVCM
$1.41B
$67.4K ﹤0.01%
6,695
+5,693
+568% +$60.3K
BH.A icon
4747
Biglari Holdings Class A
BH.A
$1.12B
$67.3K ﹤0.01%
32
+28
+700% +$45.9K
CHPT icon
4748
ChargePoint
CHPT
$238M
$67K ﹤0.01%
11,331
+1,500
+15% +$9.82K
KULR icon
4749
KULR Technology Group
KULR
$105M
$66.3K ﹤0.01%
17,412
-5,475
-24% -$18.2K
BVFL icon
4750
BV Financial
BVFL
$178M
$66.3K ﹤0.01%
3,131
+1,785
+133% +$35.7K

Similar funds

Citigroup's Q2 2026 Portfolio in Review

As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup deployed $27.6B of net new capital in Q2 2026, opening 553 new positions and adding to 3,286 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.

  • Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
  • Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
  • Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
  • Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
  • Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
  • Citigroup opened 553 new positions and closed 758 in Q2 2026.
  • Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.